
FRIDAY, Nov. , 2021Pfizer Inc. announced Friday that its experimental COVID-19 pill slashed the risk of hospitalization and death by 89% in infected high-risk people. The five-day treatment, when given within three days of infection, was so effective in a clinical trial that an independent monitoring committee recommended the trial be stopped early, Pfizer said.… read on > read on >